Atla Group Co., Ltd. (6029) said on Nov. 17 its board approved subscribing to 156,154 new shares of REMED JAPAN Co., Ltd. for ¥78.077 million, taking 35% of the voting rights and making it an equity-method affiliate.
REMED JAPAN, based in Tokyo's Chuo Ward and headed by Lee Geun-yong, sells products in Japan for its parent, KOSDAQ-listed Remed Co., Ltd. (302550), under an exclusive distribution agreement covering all Remed products. Atla Group signed a term sheet with both companies the same day.
Atla Group signed a memorandum of understanding with Remed on April 21, 2026. Remed makes non-invasive magnetic and shockwave treatment devices, including transcranial magnetic stimulation (TMS), neuromuscular magnetic stimulation (NMS) and extracorporeal shockwave therapy (ESWT) units. Atla Group plans to offer them through the network of about 3,000 clinics using its A-COMS platform for acupuncture and bonesetting clinics, and called the deal its first new-business investment under its growth strategy.
The capital increase lifts REMED JAPAN's outstanding shares to 446,154 from 290,000. Each side will nominate two of four directors, and Atla Group will appoint the auditor. All proceeds will go to working capital and marketing, not to early repayment of loans from Remed.
| Item (¥ thousand) | FY Dec. 2024 | FY Dec. 2025 |
|---|---|---|
| Sales | 155,143 | 132,895 |
| Operating loss | 43,824 | 39,639 |
| Net loss | 45,957 | 37,499 |
| Net assets | 66,339 | 28,839 |
Atla Group will also obtain a call option to buy a further 16% from Remed, priced on an EBITDA-multiple basis. Exercise would raise its stake to 51% and make REMED JAPAN a consolidated subsidiary; the company said it does not currently plan to go beyond 51%.
Next steps: signing of the definitive agreements and payment are scheduled for around early December 2026. The option can be exercised during a set period after REMED JAPAN's results for the year ending December 2028 are finalized.
| I-ne | |
| Tender offer price | ¥2,248 per share |
| Kadoya Seiyu | |
| Tender offer price | ¥2,655 per share |
| TKP Corporation | |
| Effective date | March 1, 2027 (scheduled) |
| M3, Inc. | |
| Tender offer price | ¥1,619 per share |
| Digital Hearts Holdings | |
| Consolidation ratio | 2,975,211 shares into 1 share |
| Shoei Corporation | |
| Shares transferred | 1.8 million shares |
| TOSE Co., Ltd. | |
| Effective date (scheduled) | Jan. 4, 2027 |
| NSK Ltd. | |
| Share transfer ratio (NSK:NTN) | 1:0.353 |
| M&A / TOB | 20 |
| Guidance | 7 |
| Buybacks | 11 |
| Dividends | 4 |
| Capital | 12 |
| Earnings | 16 |
| People | 3 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理,非投資建議,亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。